Bill revision could mean money for NJ drug company
(AP) -- A billion-dollar "technical revision" added to a patent bill passed by the House last week could provide huge financial benefits to one pharmaceutical company and a law firm.
US potato giant bets on biotech potatoes (Update)
A dozen years after a customer revolt forced Monsanto to ditch its genetically engineered potato, another company aims to resurrect high-tech spuds.
FDA links some prostate drugs to cancer risk
(AP) -- The Food and Drug Administration expanded the warning label on a group of prostate drugs Thursday, saying they may increase the risk of a more serious form of prostate cancer.
FDA: Breast implant problems grow with time
Don't expect breast implants to last for life, the government warned Wednesday: About 1 in 5 women who receive them for cosmetic reasons will have them removed within 10 years, and those odds are even higher ...